Management of Prolonged Menstrual Bleeding with Implanon

Initial Assessment and Exclusion of Pathology

Rule out pregnancy first in all reproductive-age women with abnormal bleeding, as this could indicate pregnancy including ectopic pregnancy 1
Assess for hemodynamic instability by checking for tachycardia or hypotension, which indicate significant blood loss requiring urgent evaluation 1
Evaluate bleeding severity, as bleeding that saturates a large pad or tampon hourly for at least 4 hours warrants concern 1
Screen for STIs, as unscheduled bleeding can indicate sexually transmitted infections, particularly in adolescents 2, 3
Consider underlying gynecological conditions, such as medication interactions, new pathologic uterine conditions, or implant fracture (rare but documented) 1
Review medication history, as women on anticoagulants have higher risk, with factor Xa inhibitors causing incidence of abnormal uterine bleeding 1

Prolonged bleeding affects approximately 18% of Implanon users and is the most common reason for discontinuation 4
In clinical trials, 64% of women experienced amenorrhea or infrequent bleeding, while 15% reported frequent or prolonged bleeding 2, 3
Unlike other continuous methods, bleeding patterns may not improve over time with Implanon 2, 3

Mefenamic acid 500 mg three times daily for 5 days showed significant cessation of bleeding within 7 days 4
Celecoxib 200 mg daily for 5 days also demonstrated efficacy 4
Low-dose combined oral contraceptives for 10-20 days can be used as a hormonal option 1
Estrogen therapy for 10-20 days can also be used as a hormonal option 4, 1

Enhanced counseling before insertion about expected bleeding patterns has been shown to reduce discontinuation rates in clinical trials 4
Reassurance that bleeding irregularities are generally not harmful is essential 4

Levonorgestrel IUD reduces menstrual blood loss by 71-95% and may be better tolerated 1
Other LARC methods should be discussed based on individual patient factors 3